Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Charlien Berghen is a surgical oncologist specializing in the management of recurrent prostate cancer, with a particular focus on advanced minimally invasive techniques. Her research centers on salvage lymph node dissection (sLND) and salvage vesiculectomy for patients experiencing disease recurrence after primary treatment. Dr. Berghen’s most cited work, a 2019 study comparing robot-assisted versus open salvage lymph node dissection in recurrent prostate cancer (13 citations), provided critical early evidence that robotic approaches can achieve comparable peri-operative and oncological outcomes to open surgery while potentially reducing morbidity. This work has helped establish robotic sLND as a viable alternative to traditional open surgery, offering patients a less invasive path to delay or avoid palliative androgen deprivation therapy. More recently, in 2024, she detailed the surgical technique and early outcomes of salvage vesiculectomy for local recurrence (3 citations), further expanding the surgical armamentarium for oligorecurrent prostate cancer. Through these contributions, Dr. Berghen is advancing the field of salvage surgery, demonstrating that precise, targeted interventions can improve quality of life and oncological control for patients facing limited prostate cancer recurrence.